N@N

Market Maker Surveillance Report. DRRX, SPU, BNSO, PTIE, CCCR, ACOR, Losing Stocks With Lowest Price Friction For Monday, Sept

^{Published on 2016-09-26 18:45:43 - WOPRAI}
 

September 26, 2016 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 5384 companies with "abnormal" market making, 1731 companies with positive Friction Factors and 4698 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Monday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Durect Corporation (NASDAQ:DRRX), SkyPeople Fruit Juice Inc (NASDAQ:SPU), Bonso Electronics International, Inc. (NASDAQ:BNSO), Pain Therapeutics (NASDAQ:PTIE), China Commercial Credit (NASDAQ:CCCR), Acorda Therapeutics, Inc. (NASDAQ:ACOR). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  DRRX    $-0.560   -0.33%    3,177,468    28.03%    3,499,400    30.87%    -321,932     -5,749  
  SPU     $-1.710   -0.17%    106,885      27.34%    174,552      44.64%    -67,667      -396    
  BNSO    $-0.220   -0.12%    60,262       32.12%    79,291       42.26%    -19,029      -865    
  PTIE    $-1.390   -0.51%    6,183,593    37.84%    6,495,934    39.75%    -312,341     -2,247  
  CCCR    $-0.250   -0.11%    31,356       18.06%    45,145       26.00%    -13,789      -552    
  ACOR    $-4.290   -0.16%    799,555      28.26%    905,116      31.99%    -105,561     -246    

For example, the chart above shows DRRX with a dollar loss Monday of $-0.56000 and a Friction Factor of -5,749 shares. That means that it only took 5,749 more shares of selling than buying to move DRRX lower by one penny. This means the Market Makers are allowing the stock to drop quickly (low friction). The combination of low friction and negative market direction can drive prices lower faster than normal.

Durect Corporation (NASDAQ:DRRX) - DURECT Corporation, a biopharmaceutical company, researches and develops therapies based on its epigenomic regulator program and proprietary drug delivery platforms. The company offers ALZET product line that includes osmotic pumps and accessories used for experimental research in mice, rats, and other laboratory animals; and a range of biodegradable polymers for use as raw materials for pharmaceutical and medical devices under the LACTEL brand. It also develops DUR-928, an endogenous bioavailable small molecule that is in Phase Ib clinical trial for the treatment of chronic metabolic disease, as well as to treat acute organ injury, including acute kidney injury and other conditions. In addition, the company develops POSIMIR, a formulation of bupivacaine that is in Phase III clinical trial for the treatment of post-surgical pain; REMOXY, an oral oxycodone gelatin capsule for chronic pain; ORADUR-ADHD, a drug candidate, which is in Phase III clinical trial for the treatment of attention deficit hyperactivity disorder; and ELADUR, a transdermal bupivacaine patch for the treatment of pain.. Further, it develops Relday, an injectable formulation of risperidone to treat the symptoms of schizophrenia and bipolar I disorder in adults and teenagers; ORADUR-based opioid for chronic pain; and various research programs for medical diseases and conditions, such as central nervous system diseases and disorders, cardiovascular diseases, ophthalmic conditions, and metabolic disorders. DURECT Corporation markets and sells its ALZET and LACTEL product lines through direct sales force in the United States, Japan, Europe, and internationally. The company has collaboration agreements with Santen Pharmaceutical Co., Ltd.; Impax Laboratories, Inc.; Zogenix, Inc.; and Pain Therapeutics, Inc. DURECT Corporation was founded in 1998 and is headquartered in Cupertino, California..

SkyPeople Fruit Juice Inc (NASDAQ:SPU) - SkyPeople Fruit Juice, Inc., through its subsidiaries, produces and sells fruit juice concentrates, fruit beverages, and other fruit-related products in the People s Republic of China and internationally. The company operates through six segments: Concentrated Apple Juice and Apple Aroma, Concentrated Kiwifruit Juice and Kiwifruit Puree, Concentrated Pear Juice, Fruit Juice Beverages, Fresh Fruits and Vegetables, and Others. It offers fruit juice concentrates, such as fruit purees, concentrated fruit purees, and concentrated fruit juices; concentrated apple, pear, and kiwifruit juices; pure fruit juice and fruit cider beverages, including apple juice, pear juice, kiwifruit juice, mulberry juice, kiwifruit cider, mulberry cider, peach juice, and pomegranate juice; and fresh fruits and vegetables, fructose, concentrated fruit and vegetable juices, and turnjujube juice, as well as other by products, such as kiwifruit seeds. The company sells its products directly to end-users; to hotels, supermarkets, and other outlets; and through trade Websites, as well as indirectly through distributors and agents. SkyPeople Fruit Juice, Inc. is headquartered in Xi an, the People s Republic of China..

Bonso Electronics International, Inc. (NASDAQ:BNSO) - Bonso Electronics International Inc. designs, manufactures, and sells various electronic scales and weighing instruments, pet electronics products, and other products in Hong Kong and the People s Republic of China. The company s sensor-based scale products include bathroom, kitchen, office, jewelry, laboratory, postal, and industrial scales that are used in consumer, commercial, and industrial applications. It also offers electrical pet care products, including a bark control device; manufactures tools and molds for scales and pet electronics products; and sells scrap materials. The company serves private label original equipment manufacturers, original brand manufacturers, and original design manufacturers. It also exports its products to the United States, Germany, Asia, the United Kingdom, Australia, and Africa. The company was formerly known as Golden Virtue Limited and changed its name to Bonso Electronics International, Inc. in September 1988. Bonso Electronics International Inc. was founded in 1988 and is based in Tsimshatsui, Hong Kong..

Pain Therapeutics (NASDAQ:PTIE) - Pain Therapeutics, Inc., a biopharmaceutical company, develops novel drugs in the United States. The company s lead drug candidate is REMOXY, a proprietary abuse-deterrent oral formulation of oxycodone for pain relief. It also develops FENROCK, a proprietary abuse-deterrent transdermal pain patch for pain relief; and PTI-125, a small molecule drug candidate to treat Alzheimer s disease and other neurological disorders. The company was founded in 1998 and is based in Austin, Texas..

China Commercial Credit (NASDAQ:CCCR) - CCR VIDEO CORP.

Acorda Therapeutics, Inc. (NASDAQ:ACOR) - Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); Zanaflex Capsules and tablets for the management of spasticity; and Qutenza, a dermal patch for the management of neuropathic pain associated with post-herpetic neuralgia. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops CVT-301 that is in the Phase IIb clinical trial for the treatment of OFF periods in Parkinson s disease; CVT-427, which has completed a Phase I clinical trial to treat migraine; and Ampyra/Dalfampridine that is in the Phase I pharmacokinetic studies for the treatment of chronic post-stroke deficits. Further, it develops Plumiaz, a proprietary nasal spray formulation of diazepam to treat people with epilepsy; Cimaglermin alfa/Neuregulins that has completed a Phase I clinical trial for the treatment of heart failure; Remyelinating Antibodies Program, which is in Phase I clinical trial for the treatment of MS; and Chondroitinase Program that is in research stage for the treatment of spinal cord injury. The company has collaborations and license agreements with Biogen International GmbH; Alkermes plc; Rush-Presbyterian St. Luke's Medical Center; Alkermes, Inc.; SK Biopharmaceuticals Co., Ltd.; Astellas Pharma Europe Ltd.; Canadian Spinal Research Organization; Cambridge Enterprise Limited and King's College London; Mayo Foundation for Education and Research; Paion AG; and Brigham and Women s Hospital, Inc. Acorda Therapeutics, Inc. was founded in 1995 and is headquartered in Ardsley, New York..

About BUYINS.NET

BUYINS.NET, http://www.buyins.net, monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS Friction Factor - Market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements" Naked Shorts (RegSho) - Tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING Earnings - Predicts probability, price move and length of move before and after all US stock earnings reports Seasonality - Predicts probability, price move and length of move based on exact time of year for all US stocks Group Correlation - Tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups SqueezeTrigger - Massive database that tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock. Valuation - Tracks all known valuation models and applies them. GATS - Tracks and quantifies known trading strategies by backtesting, optimizing and running genetic algorithms and neural networks to ascertain best trading strategies. PatternScan - Automates tracking of every technical pattern and predicts next move in stocks. Insider - Tracks insiders trading records and determines trading performance. Trades by higher-level insiders are generally more predictive than trades by lower level insiders Events - Tracks patterns directly correlated to specific events.

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. [symbol] has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net